Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers

The FDA is “willing to review” an updated submission for Capricor’s Duchenne cell therapy, its CEO said. Elsewhere, a heart drug battle spilled into court and Rigel priced the first “Protac” medicine.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

Congo's Ebola cases rising at record pace

The Ebola virus is spreading rapidly in the DRC. In Kinshasa, a city of millions, fears of a serious health crisis are growing. Hospitals are scrambling to prepare for emergencies as best as they can.

Congo's Ebola cases rising at record pace

The Ebola virus is spreading rapidly in the DRC. In Kinshasa, a city of millions, fears of a serious health crisis are growing. Hospitals are scrambling to prepare for emergencies as best as they can.

Congo's Ebola cases rising at record pace

The Ebola virus is spreading rapidly in the DRC. In Kinshasa, a city of millions, fears of a serious health crisis are growing. Hospitals are scrambling to prepare for emergencies as best as they can.

More from Friday 14 August →